Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG has today closed an oversubscribed series A financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test.

The future of antibiotics depends on all of us! Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.

Despite the fact that the spread of resistant bacteria is seen as one of the biggest global threats, pharmaceutical companies are pulling out of research into new antibiotics.

For the first time Resistell with its Rapid AST made it to TOP100 this year! We are super proud and have big ambitions to climb up the list! Stay tuned!

Join us in Zurich at the Annual Meeting of Swiss Society for Microbiology and learn more about our rapid AST solution. We invite you to our booth number 24. See you soon!

In the immensity of the cosmos, could life develop on another planet than Earth? Nano-motion device invented be Sandor Kasas and Giovanni Dietler from EPFL Lausanne...

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.